{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:52:38Z","timestamp":1789487558119,"version":"build-2803163510"},"reference-count":45,"publisher":"American Chemical Society (ACS)","issue":"36","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203134\/A\/16\/Z"],"award-info":[{"award-number":["203134\/A\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-026519"],"award-info":[{"award-number":["INV-026519"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-039628"],"award-info":[{"award-number":["INV-039628"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-071352"],"award-info":[{"award-number":["INV-071352"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1054480"],"award-info":[{"award-number":["OPP1054480"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 R01 AI151639 01"],"award-info":[{"award-number":["1 R01 AI151639 01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI152533"],"award-info":[{"award-number":["R01 AI152533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tres Cantos OpenLab Foundation","award":["TC292"],"award-info":[{"award-number":["TC292"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite considerable progress in prevention, treatment, and eradication efforts, malaria continues to impose a significant public health and socioeconomic burden for many countries around the globe. With the effectiveness of current treatment options partially or totally compromised due to resistance, the validation of new targets and the development of new drugs that can reach the demanding standards required for the treatment of this disease represent an urgent and considerable challenge. Herein, we report the evaluation of approximately 48 200-compound library selected from the GSK collection against PfGCN5. From the 6 initial hits with pIC50 &amp;gt; 5, two compounds were progressed for further in vitro profiling and optimization. Computational and medicinal chemistry efforts delivered significantly improved compounds 21h and 41d with pIC50 within the submicromolar range (pIC50 6.6 and 7.0, respectively), but unfortunately, the lead compounds did not show potent in vitro antiparasitic activity. Although further studies are still necessary, our initial data suggest that targeting PfGCN5 to develop new antimalarial compounds might be challenging.<\/jats:p>","DOI":"10.1021\/acsomega.6c08259","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:26:10Z","timestamp":1788409570000},"page":"54730-54761","source":"Crossref","is-referenced-by-count":0,"title":["Identification,\nStructure\u2013Activity Relationship\n(SAR), and Biological Evaluation of New Chemical Series as Malaria\nParasite\n                    <i>Pf<\/i>\n                    GCN5 Bromodomain Inhibitors"],"prefix":"10.1021","volume":"11","author":[{"given":"Pedro","family":"Martin-Acosta","sequence":"first","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas H. K.","family":"Al Temimi","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luma","family":"Godoy Magalhaes","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Salamanca-Viloria","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Martin Hernando","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Villegas","sequence":"additional","affiliation":[{"name":"Charles River Laboratories, PTM , Severo Ochoa 2 , , ,","place":["Tres Cantos, Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Franco Hidalgo","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"McMillan","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Plater","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Gabarro","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Calderon","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Santos","family":"Martinez-Martinez","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliana","family":"D\u2019Oria","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair L.","family":"Siqueira-Neto","sequence":"additional","affiliation":[{"name":"University of California , , San Diego, , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3986-5880","authenticated-orcid":true,"given":"Barbara","family":"Forte","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[{"name":"University of California , , San Diego, , ,","place":["La Jolla, California, United States, 92093"]},{"name":"University of California , , San Diego, , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lisa","family":"Valenciano","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-1113","authenticated-orcid":true,"given":"Beatriz","family":"Baragan\u0303a","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-506X","authenticated-orcid":true,"given":"Sonia","family":"Moliner-Cubel","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-2882","authenticated-orcid":true,"given":"Francisco Javier","family":"Gamo","sequence":"additional","affiliation":[{"name":"Global Health Medicines R&D, GSK Tres Cantos , ,","place":["Madrid, Spain, 28760"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"9","key":"2026091510084278300_cit1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","article-title":"Key gaps in the knowledge of Plasmodium\nvivax, a neglected human malaria parasite","volume":"9","author":"Mueller","year":"2009","journal-title":"Lancet\nInfect. Dis"},{"issue":"13","key":"2026091510084278300_cit2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of Artemisinin-Resistant\nMalaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"10","key":"2026091510084278300_cit3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1021\/ml200135p","article-title":"An Invitation\nto Open Innovation in Malaria Drug Discovery: 47 Quality Starting\nPoints from the TCAMS","volume":"2","author":"Caldero\u0301n","year":"2011","journal-title":"ACS Med. Chem. Lett"},{"issue":"6","key":"2026091510084278300_cit4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.drudis.2019.04.005","article-title":"Collaborative\ndrug discovery and the Tres Cantos Antimalarial Set (TCAMS)","volume":"24","author":"Cabrera","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"11","key":"2026091510084278300_cit5","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1021\/acschembio.1c00512","article-title":"High-Content Phenotypic Screen of a Focused TCAMS Drug\nLibrary Identifies Novel Disruptors of the Malaria Parasite Calcium\nDynamics","volume":"16","author":"Chia","year":"2021","journal-title":"ACS Chem. Biol"},{"issue":"3","key":"2026091510084278300_cit6","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1128\/AAC.02110-15","article-title":"Discovery\nof Dual-Stage Malaria Inhibitors\nwith New Targets","volume":"60","author":"Raphemot","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"issue":"686","key":"2026091510084278300_cit7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adc9249","article-title":"Cytoplasmic isoleucyl tRNA synthetase as an attractive\nmultistage antimalarial drug target","volume":"15","author":"Istvan","year":"2023","journal-title":"Sci. Transl.\nMed"},{"issue":"6","key":"2026091510084278300_cit8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.pt.2021.01.009","article-title":"MalDA, Accelerating\nMalaria Drug Discovery","volume":"37","author":"Yang","year":"2021","journal-title":"Trends Parasitol"},{"issue":"10","key":"2026091510084278300_cit9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"10","key":"2026091510084278300_cit10","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","article-title":"Prioritization\nof Molecular Targets for Antimalarial\nDrug Discovery","volume":"7","author":"Forte","year":"2021","journal-title":"ACS Infect. Dis"},{"issue":"22","key":"2026091510084278300_cit11","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.1093\/nar\/gkz1044","article-title":"Epigenetic reader complexes of the human malaria parasite,\nPlasmodium falciparum","volume":"47","author":"Hoeijmakers","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2026091510084278300_cit12","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1128\/EC.00062-07","article-title":"PfGCN5-mediated\nhistone H3 acetylation plays a key role in gene expression\nin Plasmodium falciparum","volume":"6","author":"Cui","year":"2007","journal-title":"Eukaryotic Cell"},{"issue":"1","key":"2026091510084278300_cit13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13072-015-0029-1","article-title":"A comprehensive epigenome map of Plasmodium falciparum\nreveals unique mechanisms of transcriptional regulation and identifies\nH3K36me2 as a global mark of gene suppression","volume":"8","author":"Karmodiya","year":"2015","journal-title":"Epigenet. Chromatin"},{"issue":"8","key":"2026091510084278300_cit14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009351","article-title":"A unique GCN5\nhistone acetyltransferase complex controls erythrocyte invasion and\nvirulence in the malaria parasite Plasmodium falciparum","volume":"17","author":"Miao","year":"2021","journal-title":"PLoS Pathog"},{"issue":"6388","key":"2026091510084278300_cit15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap7847","article-title":"Uncovering\nthe essential\ngenes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"issue":"2","key":"2026091510084278300_cit16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cell.2017.06.030","article-title":"Functional Profiling\nof a Plasmodium Genome Reveals an Abundance of Essential Genes","volume":"170","author":"Bushell","year":"2017","journal-title":"Cell"},{"issue":"11","key":"2026091510084278300_cit17","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1021\/acsinfecdis.1c00387","article-title":"Expanding Bromodomain Targeting into Neglected\nParasitic Diseases","volume":"7","author":"Tallant","year":"2021","journal-title":"ACS Infect. Dis"},{"issue":"10","key":"2026091510084278300_cit18","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1021\/acschembio.8b00705","article-title":"Modulating PCAF\/GCN5 Immune Cell Function through\na PROTAC Approach","volume":"13","author":"Bassi","year":"2018","journal-title":"ACS Chem. Biol"},{"issue":"7","key":"2026091510084278300_cit19","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1128\/EC.00063-08","article-title":"Histone acetyltransferase\ninhibitor anacardic acid causes changes in global gene expression\nduring in vitro Plasmodium falciparum development","volume":"7","author":"Cui","year":"2008","journal-title":"Eukaryotic Cell"},{"issue":"10","key":"2026091510084278300_cit20","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/s16101616","article-title":"Arbitrarily\nAccessible 3D Microfluidic Device for Combinatorial High-Throughput\nDrug Screening","volume":"16","author":"Chen","year":"2016","journal-title":"Sensors"},{"issue":"3","key":"2026091510084278300_cit21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/anie.201610816","article-title":"Discovery\nof a PCAF\nBromodomain Chemical Probe","volume":"56","author":"Moustakim","year":"2017","journal-title":"Angew. Chem., Int.\nEd"},{"issue":"23","key":"2026091510084278300_cit22","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1111\/febs.13067","article-title":"Histone H3K9 acetylation level modulates gene expression\nand may affect parasite growth in human malaria parasite Plasmodium\nfalciparum","volume":"281","author":"Srivastava","year":"2014","journal-title":"FEBS J"},{"key":"2026091510084278300_cit23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejmech.2017.06.009","article-title":"Designing novel\ninhibitors against histone acetyltransferase\n(HAT: GCN5) of Plasmodium falciparum","volume":"138","author":"Kumar","year":"2017","journal-title":"Eur. J.\nMed. Chem"},{"issue":"21","key":"2026091510084278300_cit24","doi-asserted-by":"publisher","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators\nof histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J. Biol.\nChem"},{"issue":"30","key":"2026091510084278300_cit25","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1002\/anie.200453879","article-title":"Design, synthesis, and biological evaluation of a small-molecule\ninhibitor of the histone acetyltransferase Gcn5","volume":"43","author":"Biel","year":"2004","journal-title":"Angew. Chem., Int. Ed"},{"issue":"49","key":"2026091510084278300_cit26","doi-asserted-by":"publisher","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin,\na novel\np300\/CREB-binding protein-specific inhibitor of acetyltransferase,\nrepresses the acetylation of histone\/nonhistone proteins and histone\nacetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem"},{"issue":"2","key":"2026091510084278300_cit27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1021\/jm800885d","article-title":"A novel\nhistone acetyltransferase inhibitor modulating\nGcn5 network: cyclopentylidene-[4-(4\u2019-chlorophenyl)thiazol-2-yl)hydrazone","volume":"52","author":"Chimenti","year":"2009","journal-title":"J. Med. Chem"},{"issue":"6","key":"2026091510084278300_cit28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1021\/cb4000597","article-title":"Probing p300\/CBP associated factor (PCAF)-dependent\npathways with a small molecule inhibitor","volume":"8","author":"Modak","year":"2013","journal-title":"ACS\nChem. Biol"},{"issue":"6","key":"2026091510084278300_cit29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/2472555218768497","article-title":"Nuisance Compounds,\nPAINS Filters, and Dark Chemical Matter in the GSK HTS Collection","volume":"23","author":"Chakravorty","year":"2018","journal-title":"SLAS Discovery"},{"issue":"2","key":"2026091510084278300_cit30","first-page":"248","article-title":"An Elementary\nMethod of Cluster Analysis","volume":"31","author":"Tanimoto","year":"1958","journal-title":"Bull. Chem. Soc.\nJpn"},{"key":"2026091510084278300_cit31","volume-title":"Glide","year":"2021"},{"key":"2026091510084278300_cit32","volume-title":"Bromodomain\nfrom Plasmodium Faciparum Gcn5, complexed with compound","author":"Lin","year":"2016"},{"issue":"17","key":"2026091510084278300_cit33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.drudis.2011.06.001","article-title":"Getting physical\nin drug discovery II: the impact of chromatographic hydrophobicity\nmeasurements and aromaticity","volume":"16","author":"Young","year":"2011","journal-title":"Drug Discovery\nToday"},{"issue":"2","key":"2026091510084278300_cit34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acs.jmedchem.6b01566","article-title":"Discovery of a Potent,\nCell Penetrant, and Selective\np300\/CBP-Associated Factor (PCAF)\/General Control Nonderepressible\n5 (GCN5) Bromodomain Chemical Probe","volume":"60","author":"Humphreys","year":"2017","journal-title":"J. Med.\nChem"},{"issue":"27","key":"2026091510084278300_cit35","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1039\/D0OB00506A","article-title":"New\ninhibitors for the BPTF bromodomain enabled by structural biology\nand biophysical assay development","volume":"18","author":"Ycas","year":"2020","journal-title":"Org. Biomol.\nChem"},{"issue":"35","key":"2026091510084278300_cit36","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1021\/acs.biochem.7b00648","article-title":"Specific Acetylation Patterns of H2A.Z Form Transient\nInteractions with the BPTF Bromodomain","volume":"56","author":"Perell","year":"2017","journal-title":"Biochemistry"},{"issue":"1","key":"2026091510084278300_cit37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s43556-023-00127-1","article-title":"Targeting bromodomain-containing proteins: research\nadvances of drug discovery","volume":"4","author":"Pan","year":"2023","journal-title":"Mol. Biomed"},{"issue":"9","key":"2026091510084278300_cit38","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1021\/acsmedchemlett.3c00242","article-title":"Design and Characterization of 1,3-Dihydro-2H-benzo[d]azepin-2-ones\nas Rule-of-5 Compliant Bivalent BET Inhibitors","volume":"14","author":"Bamborough","year":"2023","journal-title":"ACS Med. Chem. Lett"},{"issue":"12","key":"2026091510084278300_cit39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nchembio.2210","article-title":"Potent\nand selective bivalent inhibitors of BET bromodomains","volume":"12","author":"Waring","year":"2016","journal-title":"Nat. Chem. Biol"},{"issue":"3","key":"2026091510084278300_cit40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/molecules27031003","article-title":"A Review of Modifications\nof Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine","volume":"27","author":"Kucharski","year":"2022","journal-title":"Molecules"},{"issue":"14","key":"2026091510084278300_cit41","doi-asserted-by":"publisher","first-page":"6502","DOI":"10.1039\/D1NJ05598D","article-title":"Dual quinoline-hybrid compounds with antimalarial activity against\nPlasmodium falciparum parasites","volume":"46","author":"da Silva Neto","year":"2022","journal-title":"New J. Chem"},{"issue":"1","key":"2026091510084278300_cit42","doi-asserted-by":"publisher","first-page":"15398","DOI":"10.1038\/s41598-019-51604-z","article-title":"Antimalarial\nQuinoline Drugs Inhibit \u03b2-Hematin\nand Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition\nof Cysteine Proteases","volume":"9","author":"Herraiz","year":"2019","journal-title":"Sci. Rep"},{"issue":"6","key":"2026091510084278300_cit43","doi-asserted-by":"publisher","first-page":"gkaf218","DOI":"10.1093\/nar\/gkaf218","article-title":"PfGCN5 is essential for Plasmodium falciparum\nsurvival and transmission and regulates Pf H2B.Z acetylation and chromatin\nstructure","volume":"53","author":"Tang","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2026091510084278300_cit44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41598-020-79539-w","article-title":"Histone acetyltransferase\nPfGCN5 regulates stress responsive\nand artemisinin resistance related genes in Plasmodium falciparum","volume":"11","author":"Rawat","year":"2021","journal-title":"Sci. Rep"},{"issue":"14","key":"2026091510084278300_cit45","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-tRNA\nsynthetase\nas a drug target in malaria and cryptosporidiosis","volume":"116","author":"Baragan\u0303a","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c08259","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/36\/54730\/68013017\/acsomega.6c08259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/36\/54730\/68013017\/acsomega.6c08259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:36:25Z","timestamp":1789482985000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/36\/54730\/5386757\/Identification-Structure-Activity-Relationship-SAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":45,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c08259","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}